“…Nanoparticles (NPs) selectively deliver therapeutic drugs to tumors for multimodal treatment of tumors through enhanced permeability and retention (EPR) effects. , Compared to small molecules, nanomedicines are able to improve therapeutic efficiency at lower doses and increase the bioavailability of the drug, thereby reducing side effects on normal organs. , With the help of nanocarriers, nanopharmaceutical formulations realize the above advantages. However, most of the nanocarriers used for loading drugs exhibit very low loading capacity because the nanocarriers themselves account for a much larger proportion of the nanoparticles than the drug. , In addition, the preparation of nanocarriers is a complex, hazardous, and energy-consuming process, including the use of organic solvents, high temperatures and pressures required for synthesis, and so on, which may lead to quality problems due to the variations in the process from batch to batch. , Self-assembled nanoparticles have the advantages of nanoscale drug delivery systems and a high drug loading capacity.…”